Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Vir Biotechnology Inc (NASDAQ: VIR) closed at $9.64 in the last session, up 2.88% from day before closing price of $9.37. In other words, the price has increased by $2.88 from its previous closing price. On the day, 1.11 million shares were traded. VIR stock price reached its highest trading level at $9.65 during the session, while it also had its lowest trading level at $9.2.
Ratios:
We take a closer look at VIR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.94 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 05 ’24 when de Verneuil Vanina sold 2,347 shares for $9.47 per share. The transaction valued at 22,225 led to the insider holds 61,370 shares of the business.
de Verneuil Vanina sold 1,403 shares of VIR for $10,107 on Nov 01 ’24. The EVP and General Counsel now owns 63,717 shares after completing the transaction at $7.20 per share. On Nov 05 ’24, another insider, VANINA DE VERNEUIL, who serves as the Officer of the company, bought 2,347 shares for $9.37 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIR now has a Market Capitalization of 1317845888 and an Enterprise Value of 496780224. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.75 while its Price-to-Book (P/B) ratio in mrq is 1.06. Its current Enterprise Value per Revenue stands at 6.319 whereas that against EBITDA is -0.933.
Stock Price History:
Over the past 52 weeks, VIR has reached a high of $13.09, while it has fallen to a 52-week low of $7.12. The 50-Day Moving Average of the stock is 23.64%, while the 200-Day Moving Average is calculated to be 4.66%.
Shares Statistics:
According to the various share statistics, VIR traded on average about 887.86K shares per day over the past 3-months and 1691700 shares per day over the past 10 days. A total of 134.78M shares are outstanding, with a floating share count of 88.14M. Insiders hold about 35.50% of the company’s shares, while institutions hold 51.35% stake in the company. Shares short for VIR as of 1728950400 were 5550245 with a Short Ratio of 6.25, compared to 1726185600 on 5965179. Therefore, it implies a Short% of Shares Outstanding of 5550245 and a Short% of Float of 6.6199996.
